Abstract B25: Association of variations in HLA-class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma

• Published in: Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2017-05, Vol.26 (5_Supplement), p.B25-B25
• Main Authors: Shiraishi, Kouya, Okada, Yukinori, Takahashi, Atsushi, Kamatani, Yoichiro, Ashikawa, Kyota, Momozawa, Yukihide, Kunitoh, Hideo, Matsumoto, Shingo, Takano, Atsushi, Shimizu, Kimihiro, Goto, Akiteru, Tsuta, Koji, Watanabe, Shun-ichi, Ohe, Yuichiro, Watanabe, Yukio, Goto, Yasishi, Nokihara, Hiroshi, Furuta, Koh, Yoshida, Akihiko, Goto, Koichi, Hishida, Tomoyuki, Tsuboi, Masahiro, Tsuchihara, Katsuya, Miyagi, Yohei, Nakamura, Haruhiko, Yokose, Tomoyuki, Tanaka, Katsuya, Nagashima, Toshiteru, Ohtaki, Yoichi, Maeda, Daichi, Imai, Kazuhiro, Minamiya, Yoshihiro, Sakamoto, Hiromi, Saito, Akira, Shimada, Yoko, Sunami, Kuniko, Saito, Motonobu, Yoshida, Teruhiko, Yokota, Jun, Matsuda, Fumihiko, Matsuo, Keitaro, Daigo, Yataro, Kubo, Michiaki, Kohno, Takashi
• Format: Article
• Language: English
• ISSN: 1055-9965; 1538-7755
• DOI: 10.1158/1538-7755.CARISK16-B25

Background: Lung adenocarcinoma (LADC) driven by somatic EGFR mutations is more prevalent in East Asians (30-50%) than in European/Americans (10-20%). Understanding the genetic factors underlying such LADC is required to elucidate disease etiology and to identify effective methods of prevention. Methods: We investigate genetic factors underlying the risk of this disease by conducting a genome-wide association study, followed by two validation studies, in 3,173 Japanese patients with EGFR mutation-positive lung adenocarcinoma and 15,158 controls. Results: Four loci, 5p15.33 (TERT), 6p21.3 (BTNL2, HLA-class II), 3q28 (TP63) and 17q24.2 (BPTF), previously shown to be strongly associated with overall lung adenocarcinoma risk in East Asians, were re-discovered as loci associated with a higher susceptibility to EGFR mutation-positive. Citation Format: Kouya Shiraishi, Yukinori Okada, Atsushi Takahashi, Yoichiro Kamatani, Kyota Ashikawa, Yukihide Momozawa, Hideo Kunitoh, Shingo Matsumoto, Atsushi Takano, Kimihiro Shimizu, Akiteru Goto, Koji Tsuta, Shun-ichi Watanabe, Yuichiro Ohe, Yukio Watanabe, Yasishi Goto, Hiroshi Nokihara, Koh Furuta, Akihiko Yoshida, Koichi Goto, Tomoyuki Hishida, Masahiro Tsuboi, Katsuya Tsuchihara, Yohei Miyagi, Haruhiko Nakamura, Tomoyuki Yokose, Katsuya Tanaka, Toshiteru Nagashima, Yoichi Ohtaki, Daichi Maeda, Kazuhiro Imai, Yoshihiro Minamiya, Hiromi Sakamoto, Akira Saito, Yoko Shimada, Kuniko Sunami, Motonobu Saito, Teruhiko Yoshida, Jun Yokota, Fumihiko Matsuda, Keitaro Matsuo, Yataro Daigo, Michiaki Kubo, Takashi Kohno. Association of variations in HLA-class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma. [abstract]. In: Proceedings of the AACR Special Conference: Improving Cancer Risk Prediction for Prevention and Early Detection; Nov 16-19, 2016; Orlando, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2017;26(5 Suppl):Abstract nr B25.